XI’AN LIBANG PHARMACEUTICAL CO.,LTD. founded in 1996 with the location at Xi’an of China, the centre of the northwest pharmaceutical industry, is specialized in research, development, production and distribution of generic Finished Dosage Forms and high-valued APIs. As the first and also largest supplier of generic Propofol in China, LIBANG started its business and subsequently launched a broad portfolio products covering anesthetics, cardiovascular, antineoplastic, clinical nutrition etc.
With more than 10 years growth, LIBANG has transformed into an integrated healthcare solution provider, LIBANG HEALTHCARE GROUP, with diversified fields covering APIs, pharmaceutical excipients, prescription drugs, OTC products, biomedicine, medical devices, etc. LIBANG is a technology-driven firm, with more than 8% of the annual sales revenues devoted to R&D, established a unique R&D platform to proactively follows the latest pharmaceutical technology frontier.
LIBANG now is one of Top 100 China’s Pharmaceutical Industries and also listed in the Top 20 The Most Potential Chinese Pharmaceuticals that was rated by the IMS Health.